Evusheld doses go unused, despite demand in vulnerable patients
Mar 08, 2022
Fully 80% of the drug’s supply is languishing on shelves while physicians remain uninformed or uncertain about the drug and its guidance, a new report finds.
In breakthrough, feds OK nursing home visits, group dining and activities; update infection control guidance
By
Alicia Lasek
Apr 28, 2021
After nearly a year in lockdown, nursing home residents can participate in indoor visitation, communal dining and group activities — with exceptions, the Centers for Disease Control and Prevention announced...
Nursing home residents face prolonged course of COVID, facility study finds
By
Alicia Lasek
Jun 02, 2021
Residents who develop COVID-19 may face weeks of illness, no matter how mild or severe their symptoms, according to geriatricians from Indiana University and the Regenstrief Institute, Indianapolis.
Nursing home study reveals ‘dramatic’ fluctuations in prescribing of COVID-19 meds
By
Alicia Lasek
May 26, 2023
Investigators tracked the use of COVID-19 medications in 11 U.S. nursing home chains, describing prescribing patterns that shed new light on the challenges of pandemic clinical care.
FDA says it’s time to move away from mask reuse
By
Alicia Lasek
Apr 13, 2021
Healthcare facilities should move away from decontaminating and reusing disposable masks now that U.S. respirator supply has recovered, the agency says.
Feds revoke emergency use of some respirators, mask decontamination in healthcare settings
By
Alicia Lasek
Jul 02, 2021
Healthcare personnel are no longer authorized to use certain respirators not approved by NIOSH or technology for cleaning disposable masks, the FDA says.
COVID deaths now ‘entirely preventable’ due to vaccines, CDC director says
By
Alicia Lasek
Jun 24, 2021
High vaccine efficacy in the United States means that “every death due to COVID-19 is particularly tragic because nearly every death, especially among adults … [is] entirely preventable,”...
J&J vaccine effective against COVID Delta variant, drugmaker says
By
Alicia Lasek
Jul 06, 2021
Johnson & Johnson’s single-shot COVID-19 vaccine prompts a “strong neutralizing antibody response” that lasts at least eight months, the drugmaker has announced.
FDA: Evusheld may be less effective against latest COVID variants
By
Alicia Lasek
Oct 05, 2022
Evusheld, a preventive COVID-19 antibody for high-risk patients, may lose efficacy in the face of newly emerging variants, the FDA has informed clinicians.
Study highlights nurses’ sleep challenges during pandemic
By
Alicia Lasek
Jan 28, 2022
Nurses have lost a lot of sleep during the COVID-19 pandemic, and their sleep problems are closely tied to mental health issues that can affect well-being, a new investigation finds.